Functional Skills
Market Research
Business Development
Strategic Planning
Clinical Data Management
Gene Therapy
Data Management
Regulatory Compliance
Leadership Development
Operations Management
Innovation Management
Supply Chain Integration
Change Management / Org Design
Sector Experience
Agriculture
Business Services
Healthcare
Life Sciences & Pharma
Social & Public Sector
Languages
English
Top Consulting Firms
Experience
ConvaTec
Corporate Strategy & Development
Senior Manager, Global Advanced Wound Care
5/2023 - 3/2025
Strategy and Planning
• Managed annual strategic planning process for Global AWC while managing key stakeholders, gathering market insights and preparing documents for CELT and Board read-outs
• Developed models based on internal financial and market size data to help determine key strategic priorities across the target markets
• Managed and owned inorganic evaluation process with various key stakeholders across wound care to determine if opportunities fit across AWC portfolio and engaging with external parties
• Conducted research and analysis on strategic initiatives to determine alignment with Global AWC portfolio and provide recommendations to senior leadership Competitive Insights
• Evaluated and developed insights on key wound strategic companies and key market dynamics (i.e., reimbursement changes/policies, emerging technologies/competitors on a quarterly basis
• Managed annual strategic planning process for Global AWC while managing key stakeholders, gathering market insights and preparing documents for CELT and Board read-outs
• Developed models based on internal financial and market size data to help determine key strategic priorities across the target markets
• Managed and owned inorganic evaluation process with various key stakeholders across wound care to determine if opportunities fit across AWC portfolio and engaging with external parties
• Conducted research and analysis on strategic initiatives to determine alignment with Global AWC portfolio and provide recommendations to senior leadership Competitive Insights
• Evaluated and developed insights on key wound strategic companies and key market dynamics (i.e., reimbursement changes/policies, emerging technologies/competitors on a quarterly basis
Accenture
Management Consulting
Management Consultant
3/2017 - 11/2022
Strategy and Planning
• Informed FY2021 clinical innovation strategy by evaluating client operations and identifying areas of opportunities across process and technology for investment focus for global pharmaceutical company
• Led clinical data management market research to identify key trends across top 15 pharma organizations including operating model structure, talent development and acquisition, key partnerships, data capabilities and technology investments to provide recommendations for upcoming Clinical R&D strategy
• Conducted risk assessment during post-merger integration across global drug technology portfolio (~1400 solutions) spanning across functional areas: discovery, clinical, regulatory and safety to identify any immediate regulatory or compliance risks acquiring party is inheriting and designed mitigation strategy accordingly Operations and Business Transformations
• Designed steady-state operations for post-launch of cell gene therapy (CGT) for emerging asset
• Ev
• Informed FY2021 clinical innovation strategy by evaluating client operations and identifying areas of opportunities across process and technology for investment focus for global pharmaceutical company
• Led clinical data management market research to identify key trends across top 15 pharma organizations including operating model structure, talent development and acquisition, key partnerships, data capabilities and technology investments to provide recommendations for upcoming Clinical R&D strategy
• Conducted risk assessment during post-merger integration across global drug technology portfolio (~1400 solutions) spanning across functional areas: discovery, clinical, regulatory and safety to identify any immediate regulatory or compliance risks acquiring party is inheriting and designed mitigation strategy accordingly Operations and Business Transformations
• Designed steady-state operations for post-launch of cell gene therapy (CGT) for emerging asset
• Ev
Imperial Capital, LLC
Product Management / Strategy
Technology Consultant
9/2016 - 2/2017
Strategy and Planning
• Evaluated commercialization opportunities for new innovations across various global medical markets
• Conducted financial and feasibility assessment to determine product launches for U.S. and E.U markets Business Development
• Presented business, technology and strategy plans to potential funders and secured $100K in funding
• Created partnerships with funders that allowed technology to continue R&D and identify new medical applications for the product
• Evaluated commercialization opportunities for new innovations across various global medical markets
• Conducted financial and feasibility assessment to determine product launches for U.S. and E.U markets Business Development
• Presented business, technology and strategy plans to potential funders and secured $100K in funding
• Created partnerships with funders that allowed technology to continue R&D and identify new medical applications for the product
University of Pennsylvania School of Dental Medicine
Research
Clinical Researcher
6/2011 - 1/2014
• Investigated new analgesic drugs in Phase II and III clinical trials utilizing oral surgery patients as the model
• Designed retrospective study for rare bone disease on NIH sponsored natural disease cohort
• Worked on NIH funded studies in retrospective studies for rare disease
• Designed retrospective study for rare bone disease on NIH sponsored natural disease cohort
• Worked on NIH funded studies in retrospective studies for rare disease